Erratum: Nogo-B promotes the epithelial-mesenchymal transition in HeLa cervical cancer cells via Fibulin-5 (Oncol Rep (2013) 29 (109‑116) DOI: 10.3892/or.2012.2069);Nogo-B promotes the epithelial-mesenchymal transition in HeLa cervical cancer cells via Fibulin-5

Oncology Reports

Volumn 29, Issue 1, 2013, Pages 109-116

  Xiao, Wei ^a   Zhou, Shumin ^a   Xu, Hua ^b   Li, Heng ^b   He, Guoqing ^a   Liu, Yingle ^a   Qi, Yipeng ^b  

^a WUHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cervical cancer metastasis; Epithelial mesenchymal transition; Fibulin 5; Nogo B

Indexed keywords

CELL PROTEIN; FIBULIN 5; NAGO B PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PSEUDOPOD; RNA INTERFERENCE; UTERINE CERVIX CANCER;

EID: 84872843821     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2022.8311     Document Type: Erratum

References (31)

1. zur Hausen H: Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13, 1991.
2. Lee MY, Chou CY, Tang MJ and Shen MR: Epithelial-mesenchymal transition in cervical cancer: correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 14: 4743-4750, 2008.
3. Hay ED: An overview of epithelio-mesenchymal transformation. Acta Anat 154: 8-20, 1995.
4. Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454, 2002.
5. Yang J and Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829, 2008.
6. Oertle T, Merkler D and Schwab ME: Do cancer cells die because of Nogo-B? Oncogene 22: 1390-1399, 2003.
7. Su Z, Cao L, Zhu Y, et al: Nogo enhances the adhesion of olfactory ensheathing cells and inhibits their migration. J Cell Sci 120: 1877-1887, 2007.
8. Qi B, Qi Y, Watari A, et al: Pro-apoptotic ASY/Nogo-B protein associates with ASYIP. J Cell Physiol 196: 312-318, 2003.
9. Kuang E, Wan Q, Li X, Xu H, Zou T and Qi Y: ER stress triggers apoptosis induced by Nogo-B/ASY overexpression. Exp Cell Res 312: 1983-1988, 2006.
10. Liao H, Duka T, Teng FY, et al: Nogo-66 and myelin-associated glycoprotein (MAG) inhibit the adhesion and migration of Nogo-66 receptor expressing human glioma cells. J Neurochem 90: 1156-1162, 2004.
11. Miao RQ, Gao Y, Harrison KD, et al: Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci USA 103: 10997-11002, 2006.
12. Albig AR and Schiemann WP: Fibulin-5 function during tumorigenesis. Future Oncol 1: 23-35, 2005.
13. Nakamura T, Ruiz-Lozano P, Lindner V, et al: DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J Biol Chem 274: 22476-22483, 1999.
14. Nakamura T, Lozano PR, Ikeda Y, et al: Fibulin-5/DANCE is essential for elastogenesis in vivo. Nature 415: 171-175, 2002.
15. Albig AR, Neil JR and Schiemann WP: Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 66: 2621-2629, 2006.
16. Zhou S, Xiao W, Wan Q, et al: Nogo-B mediates HeLa cell adhesion and motility through binding of Fibulin-5. Biochem Biophys Res Commun 398: 247-253, 2010.
17. Matsukura T and Sugase M: Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger. Int J Gynecol Cancer 18: 1042-1050, 2008.
18. Munoz N, Bosch FX, de Sanjose S, et al: Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527, 2003.
19. zur Hausen H: Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2: 342-350, 2002.
20. Care A, Catalucci D, Felicetti F, et al: MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618, 2007.
21. Liang X: EMT: new signals from the invasive front. Oral Oncol 47: 686-687, 2011.
22. Christofori G: New signals from the invasive front. Nature 441: 444-450, 2006.
23. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
24. Peinado H, Olmeda D and Cano A: Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 7: 415-428, 2007.
25. Christofori G and Semb H: The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73-76, 1999.
26. Miettinen PJ, Ebner R, Lopez AR and Derynck R: TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors. J Cell Biol 127: 2021-2036, 1994.
27. Zavadil J and Bottinger EP: TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774, 2005.
28. Li Q, Qi B, Oka K, et al: Link of a new type of apoptosis-inducing gene ASY/Nogo-B to human cancer. Oncogene 20: 3929-3936, 2001.
29. Acevedo L, Yu J, Erdjument-Bromage H, et al: A new role for Nogo as a regulator of vascular remodeling. Nat Med 10: 382-388, 2004.
30. Van Haastert PJ: How cells use pseudopods for persistent movement and navigation. Sci Signal 4: 6, 2011.
31. Lee YH, Albig AR, Regner M, Schiemann BJ and Schiemann WP: Fibulin-5 initiates epithelial-mesenchymal transition (EMT) and enhances EMT induced by TGF-beta in mammary epithelial cells via a MMP-dependent mechanism. Carcinogenesis 29: 2243-2251, 2008.